DTC Drug Ads Under Fire

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

NEW YORK Commercial Alert has collected the endorsement of 211 medical school professors for a proposed ban on all direct-to-consumer drug advertising, the organization said today.

The watchdog group said it would present the petition to the Food and Drug Administration, which starts a DTC rules review on Nov. 1.

The professors’ statement posits that DTC advertising “intrudes” on the doctor-patient relationship by inviting the latter to insist on being prescribed branded medicines. Doctors then must take time explaining to patients why those brands may not be the best drugs for them, the statement says.

The





AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in